ebook Munafa Stock Market Course + Intraday & FNO calls  

       

DGX announcements Quest Diagnostics Incorporated announcements and dividends declared NYSE

Quest Diagnostics Incorporated Complete list of announcements declared & dividend announcements by Quest Diagnostics Incorporated DGX

Quest Diagnostics Incorporated DGX listed on NYSE and deals in Health Care Medical Specialities

Announcements and dividends declared by Quest Diagnostics Incorporated DGX

: Quest Diagnostics profit falls 12%, but beats estimate
Quest Diagnostics Inc. DGX said Tuesday its third-quarter profit dropped by 12.2% to 5 million, or .96 a share, from 6 million, or .17 a share, in the year-ago quarter. Adjusted third-quarter profit fell to .22 a share from .36 a share, and b
Announcement as on 24 October 2023

: Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Quest Diagnostics Inc. DGX said Monday it has brought the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease to market and it’s now available for consumer purchase. The test helps assess the risk of getting the diseas
Announcement as on 31 July 2023

Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
Quest Diagnostics (DGX) came out with quarterly earnings of .30 per share, beating the Zacks Consensus Estimate of .23 per share. This compares to earnings of .36 per share a year ago. These figures are adjusted for non-recu
Announcement as on 26 July 2023

Quest Diagnostics (DGX) Brings New Test for Prostate Cancer
Quest Diagnostics DGX recently launched a novel prostate cancer biomarker test through its subspecialty pathology business unit, AmeriPath. The laboratory test is developed in collaboration with Envision Sciences — an Australia-ba
Announcement as on 14 July 2023

Quest Diagnostics (DGX) Advances Access to Transplant Services
Quest Diagnostics DGX recently unveiled Quest Advanced Specialized Transplant Services. The portfolio features more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results in the physician's EMR and co
Announcement as on 10 April 2023

Announcements by Quest Diagnostics Incorporated first page | Next page | Prev page |

DGX Quest Diagnostics Incorporated current price & indicator signals

Moving Averages for Quest Diagnostics Incorporated

  • 5Day Average: 235.66
  • 12Day Average: 240.35
  • 20Day Average: 239.01
  • 50Day Average: 236.65
  • 100Day Average: 218.39
  • 150Day Average: 211.6
  • 200Day Average: 205.41

DGX Indicators & signals

Indicator MACD (12,26,9)

238.76, 238.31, 1.45
Indicator MACD is in positive zone

Indicator ADX (14)

21.91, 17.38, 27.13
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 61
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of DGX Quest Diagnostics Incorporated are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Mon Sep 2026 237.62 233.81 to 238.10 0.55% 0.82 times
25 Fri Sep 2026 236.32 235.48 to 238.24 -0.11% 0.59 times
24 Thu Sep 2026 236.59 233.55 to 237.29 1.54% 0.73 times
23 Wed Sep 2026 233.00 231.92 to 238.62 -0.75% 0.89 times
22 Tue Sep 2026 234.76 227.24 to 237.29 -4.13% 2.15 times
21 Mon Sep 2026 244.88 243.93 to 248.84 -0.64% 0.72 times
18 Fri Sep 2026 246.45 244.89 to 247.63 -0.4% 1.52 times
17 Thu Sep 2026 247.45 246.26 to 248.70 0.15% 0.78 times
16 Wed Sep 2026 247.08 244.85 to 248.57 0% 0.75 times
15 Tue Sep 2026 247.08 237.21 to 248.65 3.86% 1.09 times
14 Mon Sep 2026 237.89 234.67 to 239.78 1.22% 0.77 times
11 Fri Sep 2026 235.02 229.33 to 235.12 1.68% 0.79 times

Videos related to: DGX announcements Quest Diagnostics Incorporated announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

DGX announcements Quest Diagnostics Incorporated announcements and dividends declared NYSE

 

Back to top